SCHEMBL9819072

SCHEMBL9819072

C[C@H](Oc1ccc(F)cc1)C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.65
GAA P10253 1/20 0.65
CYP2C9 P11712 1/20 0.65
PKM P14618 1/20 0.65
CYP2C19 P33261 1/20 0.65
ALDH1A1 P00352 1/20 0.64
TDP1 Q9NUW8 2/20 0.59
PPARG P37231 4/20 0.51
PPARA Q07869 4/20 0.51
SMN1; SMN2 Q16637 3/20 0.50
MAPT P10636 2/20 0.50
KMT2A Q03164 1/20 0.50
LMNA P02545 1/20 0.50
NPSR1 Q6W5P4 2/20 0.49
POLB P06746 1/20 0.47
TBXAS1 P24557 1/20 0.47
TAS1R3 Q7RTX0 1/20 0.46
TAS1R1 Q7RTX1 1/20 0.46
TAS1R2 Q8TE23 1/20 0.46
TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3081885 1.00 CYP1A2 (0.65) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL9818914 1.00 CYP1A2 (0.65) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL11154253 0.94 CYP1A2 (0.59) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL4262556 0.89 CYP1A2 (0.77) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL11511086 0.86 NR4A2 (0.61) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL6617425 0.84 ALDH1A1 (0.64) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL11550164 0.83 CYP1A2 (0.69) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL8900988 0.83 CYP1A2 (0.69) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL23368023 0.82 ALDH1A1 (0.53) CYP1A2GAACYP2C9PKMCYP2C19
SCHEMBL11209577 0.82 ALDH1A1 (0.62) CYP1A2GAACYP2C9PKMCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0230379-B1 CHROMAN- AND THIOCHROMAN-4-ACETIC ACIDS USEFUL IN THE TREATMENT OF DIABETIC COMPLICATIONS PFIZER INC. (US) 1991-04-03 EP disclosed